LumiraDx (LumiraDx) FCF Margin % : -132.57% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LumiraDx FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. LumiraDx's Free Cash Flow for the three months ended in Jun. 2023 was $-27.8 Mil. LumiraDx's Revenue for the three months ended in Jun. 2023 was $21.0 Mil. Therefore, LumiraDx's FCF Margin % for the quarter that ended in Jun. 2023 was -132.57%.

As of today, LumiraDx's current FCF Yield % is -2,589.72%.

The historical rank and industry rank for LumiraDx's FCF Margin % or its related term are showing as below:

LMDXF' s FCF Margin % Range Over the Past 10 Years
Min: -442.84 Med: -113.55 Max: -57.17
Current: -111.07

During the past 4 years, the highest FCF Margin % of LumiraDx was -57.17%. The lowest was -442.84%. And the median was -113.55%.

LMDXF's FCF Margin % is ranked worse than
79.46% of 224 companies
in the Medical Diagnostics & Research industry
Industry Median: -10.51 vs LMDXF: -111.07

LumiraDx FCF Margin % Historical Data

The historical data trend for LumiraDx's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx FCF Margin % Chart

LumiraDx Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

FCF Margin %

-442.84

-153.58

-57.17

-73.52

LumiraDx Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
FCF Margin %	Get a 7-Day Free Trial								-199.55	-132.63	-72.78	-120.64	-132.57

Competitive Comparison of LumiraDx's FCF Margin %

For the Diagnostics & Research subindustry, LumiraDx's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LumiraDx's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, LumiraDx's FCF Margin % distribution charts can be found below:

* The bar in red indicates where LumiraDx's FCF Margin % falls into.

LumiraDx FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

LumiraDx's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-187.091	/	254.476
	=	-73.52 %

LumiraDx's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-27.845	/	21.004
	=	-132.57 %

LumiraDx FCF Margin % Related Terms

Thank you for viewing the detailed overview of LumiraDx's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

LumiraDx (LumiraDx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDXF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108

Website

https://www.lumiradx.com

LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.